No valuation for ILiAD Biotechnologies is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($214.6M) and the funding record below are the closest available signals.
- ·The complete investor list: 11 names
- ·Watch ILiAD Biotechnologies: the Monday email on marks, rounds and moves
ILiAD Biotechnologies funding history
7 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Feb 2026 | Later Stage VC (Series B) | $115.0M | ▮ | ▮ |
| Oct 2022 | Seed Round | $3.0M | ▮ | ▮ |
| Aug 2022 | Early Stage VC | $42.8M | ▮ | ▮ |
| Nov 2019 | Seed Round | $4.3M | ▮ | ▮ |
| Jul 2018 | Seed Round | $550K | ▮ | ▮ |
| Jan 2018 | Seed Round | $675K | ▮ | ▮ |
| + 1 earlier rounds · a free account shows the full history | ||||
Membership and data by Private Market View
How much has ILiAD Biotechnologies raised?
ILiAD Biotechnologies has raised $215 million across 7 recorded rounds since 2017. The largest was a $675,220 seed round in Jan 2018; the most recent was an $115 million Series B in Feb 2026.
ILiAD Biotechnologies has filed 11 Form Ds with the SEC since 2017, most recently in Feb 2026 ($116 million sold to 36 investors).
How ILiAD Biotechnologies's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For ILiAD Biotechnologies, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about ILiAD Biotechnologies
- How much has ILiAD Biotechnologies raised?
- ILiAD Biotechnologies has raised $214.6M in total funding across 7 recorded rounds.
- When did ILiAD Biotechnologies last raise?
- ILiAD Biotechnologies last raised in Feb 2026 (Later Stage VC (Series B)), raising $115.0M.